As of 2026-10-04, the Relative Valuation of Revolution Medicines Inc (RVMD) is (117.43) USD. This relative valuation is based on P/E multiples. With the latest stock price at 206.64 USD, the upside of Revolution Medicines Inc based on Relative Valuation is -156.8%.
The range of the Relative Valuation is (107.94) - (125.64) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 24.9x - 29.1x | 27.0x |
| Forward P/E multiples | 25.0x - 29.8x | 27.4x |
| Fair Price | (107.94) - (125.64) | (117.43) |
| Upside | -152.2% - -160.8% | -156.8% |
| Date | P/E |
| 2026-10-02 | -47.86 |
| 2026-10-01 | -47.69 |
| 2026-09-30 | -47.54 |
| 2026-09-29 | -47.36 |
| 2026-09-28 | -46.73 |
| 2026-09-25 | -47.48 |
| 2026-09-24 | -46.29 |
| 2026-09-23 | -44.18 |
| 2026-09-22 | -44.67 |
| 2026-09-21 | -44.65 |
| 2026-09-18 | -44.23 |
| 2026-09-17 | -45.62 |
| 2026-09-16 | -45.38 |
| 2026-09-15 | -47.45 |
| 2026-09-14 | -47.51 |
| 2026-09-11 | -47.20 |
| 2026-09-10 | -47.10 |
| 2026-09-09 | -48.10 |
| 2026-09-08 | -48.02 |
| 2026-09-04 | -48.64 |
| 2026-09-03 | -48.84 |
| 2026-09-02 | -48.46 |
| 2026-09-01 | -48.61 |
| 2026-08-31 | -47.61 |
| 2026-08-28 | -48.15 |
| 2026-08-27 | -51.22 |
| 2026-08-26 | -49.90 |
| 2026-08-25 | -48.96 |
| 2026-08-24 | -49.01 |
| 2026-08-21 | -48.52 |
| 2026-08-20 | -49.04 |
| 2026-08-19 | -49.72 |
| 2026-08-18 | -50.03 |
| 2026-08-17 | -49.10 |
| 2026-08-14 | -47.18 |
| 2026-08-13 | -46.79 |
| 2026-08-12 | -47.54 |
| 2026-08-11 | -47.61 |
| 2026-08-10 | -47.94 |
| 2026-08-07 | -47.52 |
| 2026-08-06 | -45.82 |
| 2026-08-05 | -45.70 |
| 2026-08-04 | -44.81 |
| 2026-08-03 | -42.26 |
| 2026-07-31 | -43.44 |
| 2026-07-30 | -44.51 |
| 2026-07-29 | -41.90 |
| 2026-07-28 | -42.59 |
| 2026-07-27 | -43.56 |
| 2026-07-24 | -43.83 |